CIK: 1034273 - Address: 745 Fifth Avenue, 7Th Floor, New York, NY 10151
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret218-1-2-1-1-7-1-2
S%wins88755025385054

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/3/16 20:55
3/1/16
ENDPEndo International PlcL2HealthDrugPharmaceutical PreparationsHyatt MichaelNYDS-14442.1933-3-1261D-43-49-43-29-20-14-13-17-2-3-33-61-51-70
11/12/15 07:37
11/11/15
ENDPEndo International PlcL2HealthDrugPharmaceutical PreparationsHyatt MichaelNYDS.d-44455.4833-8-3262D-9-17-34-32-1910-82-151-11-75-69
11/8/11 18:00
11/8/11
ENDPEndo Pharmaceuticals Holdings IncDEHealthDrugPharmaceutical PreparationsHyatt MichaelNYDS.d-16232.3133-5-1000D43-8-22-3131411-30391-21
12/7/10 16:54
12/3/10
ENDPEndo Pharmaceuticals Holdings IncDEHealthDrugPharmaceutical PreparationsHyatt MichaelNYDS.d-36436.4333-10-4248D69737429-312-2010113-5
1/26/06 16:19
1/24/06
ENDPEndo Pharmaceuticals Holdings IncDEHealthDrugPharmaceutical PreparationsHyatt MichaelNYDS-5,50427.5233-200-44250B2-41313138
10/14/05 17:02
10/12/05
ENDPEndo Pharmaceuticals Holdings IncDEHealthDrugPharmaceutical PreparationsHyatt MichaelNYDS-6,66326.0433-256-36450M193217-8-13-1000-1-69142031
12/1/04 16:21
11/29/04
ENDPEndo Pharmaceuticals Holdings IncDEHealthDrugPharmaceutical PreparationsHyatt MichaelNYDS-80120.0222-40-5706M1419-10210-3-510-3010-250
8/11/04 19:04
8/9/04
ENDPEndo Pharmaceuticals Holdings IncDEHealthDrugPharmaceutical PreparationsHyatt MichaelNYDS-96017.4617-55-7746M1027-29-28-30-20-14-4-3-2-3202266

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact